Jan Kehr
Bromma, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Pharmacological characterization of 4-F-3-Me-α-PVP: A novel synthetic cathinone with psychostimulant effects and abuse liability in rodents.
Journal: Journal of psychopharmacology (Oxford, England)
Published: March 13, 2026
Neurochemical and behavioral evidence of high abuse liability of 3F-NEB, a novel synthetic cathinone.
Journal: European journal of pharmacology
Published: September 29, 2025
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents.
Journal: Molecular psychiatry
Published: April 08, 2025
Dysregulated acetylcholine-mediated dopamine neurotransmission in the eIF4E Tg mouse model of autism spectrum disorders.
Journal: bioRxiv : the preprint server for biology
Published: February 14, 2024
Cholinergic regulation of vascular endothelial function by human ChAT+ T cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 29, 2023
Editorial: Neuronopathic lysosomal storage diseases - specific neuronal characteristics and therapeutic approaches.
Journal: Frontiers in molecular neuroscience
Published: October 24, 2022
Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D3 Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders.
Journal: Frontiers in psychiatry
Published: October 25, 2021
Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 04, 2021
Last Updated: 09/26/2026